These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19421006)

  • 21. Quality control against misfolded proteins in the cytosol: a network for cell survival.
    Kubota H
    J Biochem; 2009 Nov; 146(5):609-16. PubMed ID: 19737776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Nucleolus as a Proteostasis Regulator.
    Amer-Sarsour F; Ashkenazi A
    Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging.
    Morimoto RI
    Genes Dev; 2008 Jun; 22(11):1427-38. PubMed ID: 18519635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.
    Chai Y; Koppenhafer SL; Bonini NM; Paulson HL
    J Neurosci; 1999 Dec; 19(23):10338-47. PubMed ID: 10575031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
    Sinnige T; Yu A; Morimoto RI
    Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUMOylation, aging and autophagy in neurodegeneration.
    Vijayakumaran S; Pountney DL
    Neurotoxicology; 2018 May; 66():53-57. PubMed ID: 29490232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid deposits: protection against toxic protein species?
    Treusch S; Cyr DM; Lindquist S
    Cell Cycle; 2009 Jun; 8(11):1668-74. PubMed ID: 19411847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular chaperones].
    Mel'nikov EE; Rotanova TV
    Bioorg Khim; 2010; 36(1):5-14. PubMed ID: 20386574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of extracellular chaperones in amyloidosis.
    Wyatt AR; Yerbury JJ; Dabbs RA; Wilson MR
    J Mol Biol; 2012 Aug; 421(4-5):499-516. PubMed ID: 22248589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein Quality Control by Molecular Chaperones in Neurodegeneration.
    Ciechanover A; Kwon YT
    Front Neurosci; 2017; 11():185. PubMed ID: 28428740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases.
    Upadhyay A; Amanullah A; Mishra R; Kumar A; Mishra A
    Mol Neurobiol; 2018 Feb; 55(2):1169-1182. PubMed ID: 28102469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein folding, misfolding and quality control: the role of molecular chaperones.
    Papsdorf K; Richter K
    Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation.
    Kriegenburg F; Ellgaard L; Hartmann-Petersen R
    FEBS J; 2012 Feb; 279(4):532-42. PubMed ID: 22177318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases.
    McAlary L; Plotkin SS; Cashman NR
    CNS Drugs; 2019 Sep; 33(9):883-904. PubMed ID: 31414322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic potential of chemical chaperones in protein folding diseases.
    Cortez L; Sim V
    Prion; 2014; 8(2):197-202. PubMed ID: 24818993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
    Bohush A; Bieganowski P; Filipek A
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chaperone-dependent amyloid assembly protects cells from prion toxicity.
    Douglas PM; Treusch S; Ren HY; Halfmann R; Duennwald ML; Lindquist S; Cyr DM
    Proc Natl Acad Sci U S A; 2008 May; 105(20):7206-11. PubMed ID: 18480252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation by Different Types of Chaperones of Amyloid Transformation of Proteins Involved in the Development of Neurodegenerative Diseases.
    Muronetz VI; Kudryavtseva SS; Leisi EV; Kurochkina LP; Barinova KV; Schmalhausen EV
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein quality control: chaperones culling corrupt conformations.
    McClellan AJ; Tam S; Kaganovich D; Frydman J
    Nat Cell Biol; 2005 Aug; 7(8):736-41. PubMed ID: 16056264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.